首页 | 本学科首页   官方微博 | 高级检索  
     

激素替代治疗对绝经后妇女心血管危险因素的影响
引用本文:吴洁,姜允飞,周重宛,胡志沁,戴鲁琴,王志群,胡娅莉. 激素替代治疗对绝经后妇女心血管危险因素的影响[J]. 江苏医药, 2000, 26(5): 350-352
作者姓名:吴洁  姜允飞  周重宛  胡志沁  戴鲁琴  王志群  胡娅莉
作者单位:210008,南京大学医学院附属鼓楼医院
摘    要:目的 探讨不同的激素替代治疗(HRT)方案对绝经后妇女心血管危险因素的影响。方法 91例绝经后妇女分为:(1)结合雌激素(CE)A组,(2)CE B组;(3)7-甲基异炔诺酮 A组;(4)Org OD14 B组;(5)炔雌醇(EE)A组;(6)EE B组。

关 键 词:激素替代治疗 绝经 心血管疾病 危险因素

Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
WU Jie,JIANG Yunfei,ZHOU Chongwan,et al.. Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women[J]. Jiangsu Medical Journal, 2000, 26(5): 350-352
Authors:WU Jie  JIANG Yunfei  ZHOU Chongwan  et al.
Affiliation:WU Jie,JIANG Yunfei,ZHOU Chongwan,et al.Department of Obstetrics and Gynaecology,Gulou Hospital of Nanjing University Medical College,Nanjing,210008
Abstract:Objective To determine the effect of hormone replacement therapy (HRT) on cardiovascular risk factors in postmenopausal women.Methods 91 patients were divided into 6 groups:(1)conjugated estrogen (CE) group A ;(2)CE group B;(3)Org OD14 group;(4)Org OD14 groupB;(5)ethinyl estradiol (EE) group A;(6)EE group B.Height,weight,waist circumference,hip circumference,blood pressure were taken;serum lipoprotein,glucose,insulin were measured before and three months after treatment.Results After treatment,systolic pressure decreased significantly in Group CE A and Group EE A,diastolic pressure decreased significantly in CE A and Org OD14 B.Triglycerin (TG),high density lipoprotein (HDL C)increased significantly and total cholesterol (TC),low density lipoprotein (LDL C),fasting plasma glucose (FPG),fasting insulin (FINS),FING/FPG decreased significantly in CE A;TG,TC,LDL C,FPG,FINS/FPG decreased significantly and HDL C increased significantly in Org OD14 B;TC,LDL C,FPG,FINS,FINS/FPG decreased significantly in EE A.Conclusion HRT is beneficial to lipid and carbohydrate metabolism in postmenopausal women which protects their cardiovascular system,and suggesting the use of CE 0 625mg or Org OD14 1 25mg or EE 0 025mg daily as an appropriate dosage.
Keywords:Hormone replacement therapy Menopause Cardiovascular disease Metabolism
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号